Draw/line
Home / Compounds / Semaglutide

Semaglutide

Semaglutide (Ozempic, Wegovy, Rybelsus): what it is approved for, what the trials showed, label warnings, and how compounded vials are measured.

FDA-approved · Evidence grade A · Reviewed

Semaglutide (Ozempic, Wegovy, Rybelsus). GLP-1 receptor agonist.

AFDA-approved. Evidence grade A: approved, large human trials.

What is Semaglutide?

Semaglutide mimics GLP-1, a gut hormone involved in appetite and blood sugar control. It is the most widely prescribed drug in its class.

Is Semaglutide FDA-approved?

Approved in several forms. Ozempic injection is approved for type 2 diabetes. Wegovy injection is approved for chronic weight management, and a higher-strength version, Wegovy HD, was approved in March 2026. A Wegovy pill was approved in December 2025 for weight management and for lowering cardiovascular risk. Oral tablets for type 2 diabetes are sold as Rybelsus and, since February 2026, under the Ozempic name.

What does the evidence show for Semaglutide?

Large, long human trials. Average weight loss in the STEP 1 trial was about 15%.

What are the known risks of Semaglutide?

The label carries a boxed warning about thyroid C-cell tumors, based on rodent studies. It is not known whether the same happens in people. The most common side effects are nausea, vomiting, diarrhea, constipation and stomach pain. Labels for this class also warn about pancreatitis.

How is Semaglutide measured?

Brand-name pens are pre-measured, so there is nothing to calculate. If a pharmacy dispenses a vial labeled in mg per mL, the Pre-mixed mode converts a prescribed dose into syringe units. FDA declared the semaglutide shortage over in February 2025, which removed the main basis for large-scale compounding.

Sources: Managed Healthcare Executive: GLP-1 pills; Prime Therapeutics: GLP-1 pipeline update, August 2026; Novo Nordisk: Wegovy and Saxenda safety information; Polsinelli: FDA compounded GLP-1 policy. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.